EUVIMEDEUVIMED entdecken
Crossref

Increase in serum vimentin levels in patients with glioma and its correlation with prognosis of patients with glioblastoma

Taiichi Saito, Yoshihiro Muragaki, Asuka Komori, Masayuki Nitta, Shunsuke Tsuzuki, Shunichi Koriyama, Bunto Ro, Takakazu Kawamata

Neurosurgical Review · 2023

DOI: 10.1007/s10143-023-02112-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurosurgical Review, 2023. Verfasst von Taiichi Saito und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Tokyo Women's Medical University, 8-1 Kawada-Cho, Shinjuku-Ku, Tokyo, 162-8666, Japan. taiichis@gmail.com. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Glioma. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early diagnosis of glioma is of great value to improve prognosis. We focused on serum vimentin levels as a useful biomarker for preoperative diagnosis. The aim of this study was to determine whether serum vimentin levels in patients with glioma are significantly higher than those of healthy adult volunteer and whether the serum vimentin level is associated with overall survival (OS) in patients with glioblastoma (GBM). This study included 52 consecutive patients with newly diagnosed glioma and a control group of 13 healthy adult volunteers. We measured serum vimentin levels in blood samples obtained from patients with glioma preoperatively and a control group. Furthermore, we investigated the correlation between serum vimentin levels and OS in patients with GBM. The serum vimentin levels of patients with glioma were significantly higher than those of the control group. The serum vimentin level of 2.9 ng/ml was the optimal value for differentiating patients with glioma from the control group with a sensitivity of 92.3% and specificity of 88.5%. The serum vimentin levels correlated significantly with immunoreactivity for survivin. In 27 patients with GBM, serum vimentin levels (cutoff value, median value 53.3 ng/ml) correlated with OS in univariate and multivariate analyses. Our study revealed that serum vimentin levels of patients with glioma are significantly higher than those of the control group. Therefore, we believe that serum vimentin level might be a useful and practical biomarker for preoperative diagnosis of glioma. Furthermore, high serum vimentin levels correlated significantly with shorter OS in patients with GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsGliomaAdultHumansVimentinPrognosisBiomarkers, Tumor

Stichwörter der Autor:innen

BiomarkerGlioblastomaGliomaSerum vimentinSurvivin

Substanzen

VimentinBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Neurosurgery, Tokyo Women's Medical University, 8-1 Kawada-Cho, Shinjuku-Ku, Tokyo, 162-8666, Japan. taiichis@gmail.com.
  • Department of Neurosurgery, Tokyo Women's Medical University, 8-1 Kawada-Cho, Shinjuku-Ku, Tokyo, 162-8666, Japan.
  • Center for Advanced Medical Engineering Research and Development (CAMED), Kobe University, Kobe City, Japan.
  • Department of Central Clinical Laboratory, Tokyo Women's Medical University, Tokyo, Japan.

Zitieren

APA

Saito, T., Muragaki, Y., Komori, A., Nitta, M., Tsuzuki, S., Koriyama, S., Ro, B., & Kawamata, T. (2023). Increase in serum vimentin levels in patients with glioma and its correlation with prognosis of patients with glioblastoma. Neurosurgical Review. https://doi.org/10.1007/s10143-023-02112-2

Vancouver

Saito T, Muragaki Y, Komori A, Nitta M, Tsuzuki S, Koriyama S, et al. Increase in serum vimentin levels in patients with glioma and its correlation with prognosis of patients with glioblastoma. Neurosurgical Review. 2023. doi:10.1007/s10143-023-02112-2

BibTeX
@article{Saito2023,
  author = {Saito, Taiichi and Muragaki, Yoshihiro and Komori, Asuka and Nitta, Masayuki and Tsuzuki, Shunsuke and Koriyama, Shunichi and Ro, Bunto and Kawamata, Takakazu},
  title = {Increase in serum vimentin levels in patients with glioma and its correlation with prognosis of patients with glioblastoma},
  journal = {Neurosurgical Review},
  year = {2023},
  doi = {10.1007/s10143-023-02112-2}
}
Kostenlos starten →